Many serious diseases are present in the body long before symptoms appear. Despite that, many are caught too late.

Blood tests may catch them, if they’re done at the right time and you’re happy with the needle, the clinic and the wait.

Most of us aren’t.

Early skips all three, using a simple urine sample to screen multiple biomarkers at home, with results in minutes.

The Lab will be available to buy in limited numbers in Spring 2027, offered first to those who register interest

The first clinical-grade urine test you can use at home, screening for multiple biomarkers linked to some of today’s most prevalent serious diseases including diabetes and pre-diabetes, cancers of the bladder and urinary tract, and problems in kidney function (alongside everyday wellness markers).

Combining advanced science, elegant design and effortless usability, Early is designed to make regular health screening as routine as brushing your teeth. Results in under five minutes, from a device small enough to live on your bathroom shelf and beautiful enough that you’ll want it there. Not a needle in sight.

With Early You aren’t just buying a piece of tech. You are entering into a partnership with us and like all good partnerships, each side has a part to play*

*Your side of the deal: You pee on the test. That’s actually it

Test stick

Disposable urine test fitted with a tiny electrochemical sensor and patented fluidics technology. These are delivered through your letterbox in line with your chosen delivery schedule and deliver results straight to the app in 5 minutes

Lab

A clinical-grade miniaturised electrochemical urinalysis system - a fraction of the size and price as the ones in laboratories and hospitals. It’s silent, beautiful, has a 3 month battery life, is waterproof and measures a panel of biomarkers to hospital-standard accuracy and all linked to serious diseases: PH, Potassium, Sodium, Blood in Urine and Glucose, with many more to follow.

“We need to detect disease at a point when we can still cure it - less invasively and more kindly. That requires looking earlier than our current systems allow. Early is part of that answer”

Mark Emberton OBE

Professor of Interventional Oncology, UCL and former Dean of Medical Sciences, University College London. And Early’s Chief Medical Officer’

Frequently asked
questions